Moving Metabolic Profiling from Mouse to Human and from Laboratory into the Clinic
Agnieszka Lichanska, Lecturer, University of Queensland, speaking at Advances in Metabolic Profiling 2007
Intergration of Isotopomer-based Metabolomics with Functional Genomics
Teresa Fan, Assistant Professor, University of Louisville, speaking at Advances in Metabolic Profiling 2007
Metabolomics Strategy to Identify Tissue Specific Drug Effects
Matej Orešic, Chief Research Scientist, VTT Technical Research Centre, speaking at the European Biomarker Summit, 2007
Novel Biomarker Discovery Using Metabolomics
Felice de Jong, Director, Metabolon Inc. speaking at the European Biomarkers Summit 2006.
LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation
Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.
Novel Approach to Active Metabolite Identification Allowing Early Access to Metabolic Profiling Studies to Improve Lead Candidate Selection
Dr. Danny van Elswijk, Screening Director, Kiadis BV, speaking at Advances in Metabolic Profiling 2005.
Identification of Major Metabolism Regulators from Metabolic Profiles
Dr. Anton Yuryev, Executive Director of Application Science, Ariadne Genomics Inc., speaking at Advances in Metabolic Profiling 2005.
Metabolomics in the Drug Discovery Process: Interactions With Other -omes
Dr Julian L. Griffin, University of Cambridge speaking at Advances in Metabolomic Profiling 2005.
Predicting Clinical Resistance to Gleevec Treatment by in vitro Applied Stable Isotope-based Dynamic Metabolic Profiling
Laszlo G. Boros, Los Angeles Biomedical Research Institute at UCLA and SIDMAP, LLC, speaking at Advances in Metabolic Profiling 2005